Scott W. Woods mainly focuses on Psychiatry, Psychosis, Schizophrenia, Prodrome and Internal medicine. Scott W. Woods interconnects Structured interview, Randomized controlled trial, Pediatrics and Clinical psychology in the investigation of issues within Psychiatry. His work deals with themes such as Young adult, Longitudinal study, First episode and Meta-analysis, which intersect with Psychosis.
His Schizophrenia study combines topics from a wide range of disciplines, such as Intervention, Neurocognitive, Severity of illness and Neuropsychology. The concepts of his Prodrome study are interwoven with issues in Schizotypal personality disorder, Clinical research, Psychometrics and At risk mental state. His research in Internal medicine intersects with topics in Endocrinology and Panic disorder.
Scott W. Woods spends much of his time researching Psychiatry, Psychosis, Clinical psychology, Schizophrenia and Prodrome. As a part of the same scientific family, Scott W. Woods mostly works in the field of Psychiatry, focusing on Internal medicine and, on occasion, Endocrinology and Placebo. His studies in Psychosis integrate themes in fields like Longitudinal study, Audiology, Young adult, Cognition and Structured interview.
His research integrates issues of Psychotherapist and Comorbidity in his study of Clinical psychology. His studies deal with areas such as Developmental psychology, Neurocognitive, First episode and Social cognition as well as Schizophrenia. Scott W. Woods studied Panic disorder and Anxiety disorder that intersect with Panic.
His primary scientific interests are in Psychosis, Prodrome, Clinical psychology, Longitudinal study and Schizophrenia. His Psychosis study is concerned with Psychiatry in general. His Prodrome research incorporates themes from Abnormality, Pediatrics, Autism spectrum disorder and Neuroscience.
The study incorporates disciplines such as Vulnerability, Psychosis risk, Perception and Social cognition in addition to Clinical psychology. His Longitudinal study study incorporates themes from Biomarker, Structured interview, Stressor and Cohort. As part of the same scientific family, Scott W. Woods usually focuses on Schizophrenia, concentrating on Machine learning and intersecting with Maturity.
The scientist’s investigation covers issues in Psychosis, Prodrome, Schizophrenia, Longitudinal study and Clinical psychology. Psychosis is a primary field of his research addressed under Psychiatry. His Psychiatry research includes elements of Disease mechanisms, Disease and Social functioning.
His study looks at the relationship between Prodrome and fields such as Cohort, as well as how they intersect with chemical problems. In his research, Sedation, Deutetrabenazine and Tardive dyskinesia is intimately related to Internal medicine, which falls under the overarching field of Schizophrenia. His Clinical psychology study combines topics in areas such as Mental illness, Cortisol awakening response, Autism spectrum disorder and Stress perception.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chlorpromazine equivalent doses for the newer atypical antipsychotics
Scott W. Woods.
The Journal of Clinical Psychiatry (2003)
Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability
Tandy J. Miller;Thomas H. McGlashan;Joanna L. Rosen;Kristen Cadenhead.
Schizophrenia Bulletin (2003)
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
David H. Barlow;Jack M. Gorman;M. Katherine Shear;Scott W. Woods.
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.
Tyrone D. Cannon;Kristin Cadenhead;Barbara Cornblatt;Scott W. Woods.
Archives of General Psychiatry (2008)
Prospective Diagnosis of the Initial Prodrome for Schizophrenia Based on the Structured Interview for Prodromal Syndromes: Preliminary Evidence of Interrater Reliability and Predictive Validity
Tandy J. Miller;Thomas H. McGlashan;Joanna Lifshey Rosen;Lubna Somjee.
American Journal of Psychiatry (2002)
Multicenter collaborative panic disorder severity scale.
M. Katherine Shear;Timothy A. Brown;David H. Barlow;Roy Money.
American Journal of Psychiatry (1997)
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.
Thomas H. McGlashan;Robert B. Zipursky;Diana Perkins;Jean Addington.
American Journal of Psychiatry (2006)
Symptom assessment in schizophrenic prodromal states.
Tandy J. Miller;Thomas H. McGlashan;Scott W. Woods;Kelly Stein.
Psychiatric Quarterly (1999)
Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
D. S. Charney;S. W. Woods;W. K. Goodman;G. R. Heninger.
Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex.
Christian Grillon;Rezvan Ameli;Scott W. Woods;Kathleen Merikangas.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: